Plasma-based S100B testing for management of traumatic brain injury in emergency setting

Plasma-based S100B testing for management of traumatic brain injury in emergency setting

Background: Serum biomarker S100B has been explored for its potential benefit to improve clinical decision-making in the management of patients suffering from traumatic brain injury (TBI), especially as a pre-head computed-tomography screening test for patients with mild TBI. Although being already...

Full description

Bibliographic Details
Main Authors: Ast, V. (Author), Eschmann, D. (Author), Froelich, M.F (Author), Haselmann, V. (Author), Jaruschewski, S. (Author), Kittel, M. (Author), Neumaier, M. (Author), Neumaier-Probst, E. (Author), Schamberger, C. (Author), Strauß, M. (Author), Trifonova, F. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2021
Subjects:
adult
aged
Article
blood sampling
brain hemorrhage
case report
clinical article
clinical decision making
cohort analysis
computer assisted tomography
controlled study
correlational study
disease severity
elbow fracture
emergency ward
faintness
female
headache
heparin
hospital admission
hospital discharge
human
Integrated diagnostics
lithium
major clinical study
male
Mild head injury
Mild traumatic brain injury
neuroimaging
physical examination
Plasma
predictive value
protein blood level
protein S100B
retrospective study
S100B
sensitivity analysis
Serum biomarker
surgical technique
traffic accident
traumatic brain injury
Traumatic brain injury
whiplash injury
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items